RadNet Inc
NASDAQ:RDNT

Watchlist Manager
RadNet Inc Logo
RadNet Inc
NASDAQ:RDNT
Watchlist
Price: 81.08 USD 2.04% Market Closed
Market Cap: 6.3B USD

RDNT's latest stock split occurred on Nov 28, 2006

The company executed a 1-for-2 stock split, meaning that for every 2 shares held, investors received 1 new share.

Before the split, RDNT traded at 2.41 per share. Afterward, the share price was about 4.9.

The adjusted shares began trading on Nov 28, 2006. This was the only stock split in RDNT's history.

Last Splits:
Nov 28, 2006
1-for-2
Pre-Split Price
4.82 2.41
Post-Split Price
4.9
Before
After
Last Splits:
Nov 28, 2006
1-for-2

RadNet Inc
Stock Splits History

RDNT Stock Splits Timeline
Nov 28, 2006
Nov 28, 2006
Split 1-for-2
/0.5
Pre-Split Price
4.82 2.41
Post-Split Price
4.9
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Dec 29, 2025
Ise Chemicals Corp
OTC:ICHMF
10-for-1
x10
32.808 32.808 USD N/A
Dec 29, 2025
Bridgestone Corp
OTC:BRDCF
2-for-1
x2
47.5 47.5 USD N/A
Dec 29, 2025
Ibiden Co Ltd
OTC:IBIDF
2-for-1
x2
71.8 71.8 USD N/A
Dec 29, 2025
Itochu Corp
OTC:ITOCF
5-for-1
x5
59.65 59.65 USD N/A
Dec 29, 2025
Sumitomo Realty & Development Co Ltd
OTC:SURDF
2-for-1
x2
47.945 47.945 USD N/A
Load More

RadNet Inc
Glance View

RadNet Inc. stands as a formidable entity in the realm of diagnostic imaging services, charting its course as a crucial component within the broader healthcare sector. Founded in 1980, the company has evolved into a vital provider of outpatient imaging services across the United States, leveraging both organic growth and strategic acquisitions. RadNet operates a network of imaging centers, equipped with cutting-edge technology and staffed by experienced radiologists and technicians. These centers offer a range of diagnostic imaging procedures, including MRI, CT, mammography, X-ray, and ultrasound. By positioning itself at the intersection of healthcare efficiency and innovation, RadNet marries technology with patient care, optimizing the process of disease detection and diagnosis. Revenue streams for RadNet primarily flow from patient payments and insurance reimbursements for services rendered. With the increasing reliance on advanced imaging techniques in modern medicine, RadNet capitalizes on the demand for accurate, timely diagnostic data from healthcare providers aiming to enhance patient care protocols. Another key revenue avenue stems from partnerships with hospitals and healthcare systems, wherein RadNet provides the technical platform and expertise, thus enabling these institutions to focus on core patient care activities. This business model not only underscores the importance of diagnostic services in preventive and restorative healthcare but also sharpens RadNet’s competitive edge through scale, efficiency, and an extensive network of service locations.

RDNT Intrinsic Value
HIDDEN
Show
Back to Top